Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Millennium Chelsea Harbour Hotel

Sep 19, 2017 8:00 AM - Sep 20, 2017 5:00 PM

Chelsea Harbour, London, SW10 0XG, United Kingdom

Registry Workshop - Preparing for Future Requirements

Session 3: Where to head in the EU? What are the Challenges for Collecting and Analysing High Quality Data in Order to be Useful for Regulatory Decisions

Session Chair(s)

Maren  von Fritschen, PharmD

Maren von Fritschen, PharmD

Head EU Regulatory Policy

Moderna, Netherlands

Registries can play an important role not only in monitoring the safety of medicines but also in providing adequate source for regulatory decision making. High quality patient registries can make valuable contributions to the evaluation and monitoring of medicines for public health benefit. The objective of the European Medicines Agency Patient Registry initiative is to facilitate discussions at an early stage in the authorisation procedure to increase use of existing patient registries and to support the creation of a new registry based on standard methodological approaches. This session will provide insides in challenges and opportunities for the use of registries in decision making processes based on case studies and the regulator’s expectations.

Speaker(s)

Jane  Moseley, DrMed, MSc

What are the expectations from the regulators?

Jane Moseley, DrMed, MSc

European Medicines Agency, Netherlands

Head of Inspections

Martine  Zimmermann, PharmD

Case study on a global registry of Soliris (eculizumab) for an additional indication

Martine Zimmermann, PharmD

Ipsen , France

Senior Vice President, Head of Global Regulatory Affairs, R&D Quality

Chay  Morgan

Case study on a recent CHMP approval for an OMP on accelerated assessment based on registry data

Chay Morgan

Biomarin (UK) Ltd., United Kingdom

Vice President Regulatory Affairs EU

Maren  von Fritschen, PharmD

Panel discussion with speakers

Maren von Fritschen, PharmD

Moderna, Netherlands

Head EU Regulatory Policy

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.